• Elfa Medicamentos filed for urgent preliminary injunctive relief on October 28, 2026, to facilitate creditor negotiations and address financial obligations.
• The measure aims to protect operations and preserve business value; the company and its subsidiaries continue operating normally.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elfa Medicamentos SA published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.